Filed: 8/12/2026ACC: 0001104659-26-094536
📋 What this filing means
KNOTT DAVID M JR filed this quarterly 13F‑HR report disclosing 84 equity positions with a total reported market value of $189.18M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
84
Positions
$189.18M
Total AUM (reported)
10.46M
Total Shares
Allocation by class
COMMON$189.18M100.0%
Portfolio Concentration
Top 3$68.48M36.2%
4–10$50.36M26.6%
11–25$44.89M23.7%
Rest$25.45M13.5%
Top 3 weight
36.2%
Top 10 weight
62.8%
Voting Authority Distribution
Total shares with voting rights: 10.46M
Sole
Full voting authority
10.46M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other84
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings84
Rows:
Alphabet Inc-Cl C
DFNDShares91.42K
TypeSH
Market value$32.30M
17.07%
Sole
91.42K
Shared
0.00
None
0.00
Apollo Global Management, Inc.
DFNDShares225K
TypeSH
Market value$26.62M
14.07%
Sole
225K
Shared
0.00
None
0.00
Syndax Pharmaceutical, Inc.
DFNDShares437.25K
TypeSH
Market value$9.56M
5.05%
Sole
437.25K
Shared
0.00
None
0.00
Xeris Biopharma Holdings, Inc.
DFNDShares1.06M
TypeSH
Market value$8.40M
4.44%
Sole
1.06M
Shared
0.00
None
0.00
Travere Therapeutics, Inc.
DFNDShares147.28K
TypeSH
Market value$8.37M
4.42%
Sole
147.28K
Shared
0.00
None
0.00
Protagonist Therapeutics, Inc
DFNDShares63K
TypeSH
Market value$7.72M
4.08%
Sole
63K
Shared
0.00
None
0.00
Bridgebio Pharma, Inc.
DFNDShares92.85K
TypeSH
Market value$6.92M
3.66%
Sole
92.85K
Shared
0.00
None
0.00
Iovance Biotherapeutics, Inc.
DFNDShares1.60M
TypeSH
Market value$6.66M
3.52%
Sole
1.60M
Shared
0.00
None
0.00
Alkermes PLC
DFNDShares121.76K
TypeSH
Market value$6.38M
3.37%
Sole
121.76K
Shared
0.00
None
0.00
JPMorgan Chase & Co.
DFNDShares18.10K
TypeSH
Market value$5.92M
3.13%
Sole
18.10K
Shared
0.00
None
0.00
Janus Henderson AAA CLO ETF
DFNDShares93.53K
TypeSH
Market value$4.72M
2.50%
Sole
93.53K
Shared
0.00
None
0.00
LPL Financial Holdings Inc.
DFNDShares16.50K
TypeSH
Market value$4.65M
2.46%
Sole
16.50K
Shared
0.00
None
0.00
Cogent Biosciences Inc.
DFNDShares111.08K
TypeSH
Market value$4.30M
2.27%
Sole
111.08K
Shared
0.00
None
0.00
TG Therapeutics, Inc.
DFNDShares66.84K
TypeSH
Market value$3.67M
1.94%
Sole
66.84K
Shared
0.00
None
0.00
Catalyst Pharmaceuticals, Inc.
DFNDShares114K
TypeSH
Market value$3.58M
1.89%
Sole
114K
Shared
0.00
None
0.00
Agios Pharmaceutical, Inc.
DFNDShares95.06K
TypeSH
Market value$3.53M
1.86%
Sole
95.06K
Shared
0.00
None
0.00
Viridian Therapeutics, Inc.
DFNDShares181K
TypeSH
Market value$3.32M
1.76%
Sole
181K
Shared
0.00
None
0.00
Relmada Therapeutics, Inc.
DFNDShares451K
TypeSH
Market value$3.12M
1.65%
Sole
451K
Shared
0.00
None
0.00
Arcus Biosciences, Inc.
DFNDShares81.24K
TypeSH
Market value$2.50M
1.32%
Sole
81.24K
Shared
0.00
None
0.00
Cybin Inc
DFNDShares370K
TypeSH
Market value$2.45M
1.29%
Sole
370K
Shared
0.00
None
0.00
SPDR S&P Biotech ETF
DFNDShares15K
TypeSH
Market value$2.37M
1.25%
Sole
15K
Shared
0.00
None
0.00
Rezolute, Inc.
DFNDShares370K
TypeSH
Market value$1.92M
1.02%
Sole
370K
Shared
0.00
None
0.00
AllianceBernstein Holding L.P.
DFNDShares48K
TypeSH
Market value$1.69M
0.89%
Sole
48K
Shared
0.00
None
0.00
Madrigal Pharmaaceuticals, Inc.
DFNDShares3K
TypeSH
Market value$1.61M
0.85%
Sole
3K
Shared
0.00
None
0.00
AtriCure, Inc.
DFNDShares51.40K
TypeSH
Market value$1.44M
0.76%
Sole
51.40K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Alphabet Inc-Cl CDFND | Common | 91.42K | SH | $32.30M 17.07% | 91.42K | 0.00 | 0.00 |
Apollo Global Management, Inc.DFND | Common | 225K | SH | $26.62M 14.07% | 225K | 0.00 | 0.00 |
Syndax Pharmaceutical, Inc.DFND | Common | 437.25K | SH | $9.56M 5.05% | 437.25K | 0.00 | 0.00 |
Xeris Biopharma Holdings, Inc.DFND | Common | 1.06M | SH | $8.40M 4.44% | 1.06M | 0.00 | 0.00 |
Travere Therapeutics, Inc.DFND | Common | 147.28K | SH | $8.37M 4.42% | 147.28K | 0.00 | 0.00 |
Protagonist Therapeutics, IncDFND | Common | 63K | SH | $7.72M 4.08% | 63K | 0.00 | 0.00 |
Bridgebio Pharma, Inc.DFND | Common | 92.85K | SH | $6.92M 3.66% | 92.85K | 0.00 | 0.00 |
Iovance Biotherapeutics, Inc.DFND | Common | 1.60M | SH | $6.66M 3.52% | 1.60M | 0.00 | 0.00 |
Alkermes PLCDFND | Common | 121.76K | SH | $6.38M 3.37% | 121.76K | 0.00 | 0.00 |
JPMorgan Chase & Co.DFND | Common | 18.10K | SH | $5.92M 3.13% | 18.10K | 0.00 | 0.00 |
Janus Henderson AAA CLO ETFDFND | Common | 93.53K | SH | $4.72M 2.50% | 93.53K | 0.00 | 0.00 |
LPL Financial Holdings Inc.DFND | Common | 16.50K | SH | $4.65M 2.46% | 16.50K | 0.00 | 0.00 |
Cogent Biosciences Inc.DFND | Common | 111.08K | SH | $4.30M 2.27% | 111.08K | 0.00 | 0.00 |
TG Therapeutics, Inc.DFND | Common | 66.84K | SH | $3.67M 1.94% | 66.84K | 0.00 | 0.00 |
Catalyst Pharmaceuticals, Inc.DFND | Common | 114K | SH | $3.58M 1.89% | 114K | 0.00 | 0.00 |
Agios Pharmaceutical, Inc.DFND | Common | 95.06K | SH | $3.53M 1.86% | 95.06K | 0.00 | 0.00 |
Viridian Therapeutics, Inc.DFND | Common | 181K | SH | $3.32M 1.76% | 181K | 0.00 | 0.00 |
Relmada Therapeutics, Inc.DFND | Common | 451K | SH | $3.12M 1.65% | 451K | 0.00 | 0.00 |
Arcus Biosciences, Inc.DFND | Common | 81.24K | SH | $2.50M 1.32% | 81.24K | 0.00 | 0.00 |
Cybin IncDFND | Common | 370K | SH | $2.45M 1.29% | 370K | 0.00 | 0.00 |
SPDR S&P Biotech ETFDFND | Common | 15K | SH | $2.37M 1.25% | 15K | 0.00 | 0.00 |
Rezolute, Inc.DFND | Common | 370K | SH | $1.92M 1.02% | 370K | 0.00 | 0.00 |
AllianceBernstein Holding L.P.DFND | Common | 48K | SH | $1.69M 0.89% | 48K | 0.00 | 0.00 |
Madrigal Pharmaaceuticals, Inc.DFND | Common | 3K | SH | $1.61M 0.85% | 3K | 0.00 | 0.00 |
AtriCure, Inc.DFND | Common | 51.40K | SH | $1.44M 0.76% | 51.40K | 0.00 | 0.00 |
Page 1 of 4